Paper Review Records
All Paper Review Records
20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
22
days
Disitamab vedotin combined with PD-1 inhibitors for postoperative adjuvant therapy in upper tract urothelial carcinoma: a retrospective exploratory case series
AuthorsYongbao Wei; Huaishan Hong; Dewen Zhong; Ruochen Zhang; Zhixuan Guo; Huang Lin; Jun Lin; Tao Li; Jinfeng Wu; Jianhui Chen; Yi Zhang
Affiliations1. Department of Urology, Shengli Clinical Medical College of Fujian Medical University, Fuzhou University Affiliated Provincial Hospital, China; 2. Department of Urology, Longyan First Affiliated Hospital of Fujian Medical University, China; 3. Department of Urology, Fujian Medical University Union Hospital, China; 4. Department of Urology, The Affiliated People’s Hospital of Fujian University of Traditional Chinese Medicine, China
26
days
Rare disease clinical trials in Italy (2022–May 2026): current trends, future challenges, and the evolving role as reporting member state
AuthorsEleonora De Paola; Fabrizio Galliccia; Raffaella Maione; Natalia Maria Verrelli; Diego Alejandro Dri
Affiliations1. Clinical Trials Office, Italian Medicines Agency (AIFA), Italy; 2. Department of Pharmacy, School of Specialisation in Hospital Pharmacy, University of Pisa, Italy
48
days
Hormophysa cuneiformis protects against methamphetamine-induced hepatotoxicity via antioxidant, anti-inflammatory, and autophagy-regulatory mechanisms: histological and biochemical studies
AuthorsMayada Elhusseiny; Rabab S. El-Kelany; Rania A. El-Shenody; Mohamed S. El-Hashash; Mostafa E. Elshobary; Samar Sami Alkafaas
Affiliations1. Histology and Cell Biology Department, Faculty of Medicine, Tanta University, Egypt; 2. Forensic Medicine and Clinical Toxicology at the Department of Forensic Medicine and Clinical Toxicology, Faculty of Medicine, Tanta University, Egypt; 3. Botany and Microbiology Department, Faculty of Science, Tanta University, Egypt; 4. Aquaculture Research, AWI-Helmholtz Centre for Polar and Marine Research, Germany; 5. Molecular Cell Biology Unit, Division of Biochemistry, Department of Chemistry, Faculty of Science, Tanta University, Egypt
50
days
Anti-tumor activity of valproic acid in EBV-positive Burkitt lymphoma via PFN2-associated PI3K/AKT pathway repression
AuthorsYongliang Zheng; Yuxiu Yang; Shouhua Zhang; Rui Liu; Zujie Lin; Yuanqiao He; Yaoling Luo; Aili He
Affiliations1. Department of Hematology, The Second Affiliated Hospital of Xi’an Jiaotong University, China; 2. Department of Hematology, The Affiliated Hospital of Jinggangshan University, China; 3. School of Pharmacy, Jiangxi Science and Technology Normal University, China; 4. Department of General Surgery, Jiangxi Provincial Children’s Hospital, The Affiliated Children’s Hospital of Nanchang Medical College, China; 5. Center of Laboratory Animal Science, Nanchang University, China; 6. Key Laboratory of New Drug Evaluation and Transformation of Jiangxi Province, China; 7. Clinical Medicine Research Center, First Affiliated Hospital of Gannan Medical University, China; 8. National-Local Joint Engineering Research Center of Biodiagnostics & Biotherapy, The Second Affiliated Hospital of Xi’an Jiaotong University, China; 9. Department of Tumor and Immunology, Precision Medical Institute, Xi’an Jiaotong University, China; 10. Xi’an Key Laboratory of Hematological Diseases, China
58
days
Male sexual dysfunction associated with TNF-α inhibitors: an indication-stratified global pharmacovigilance analysis
AuthorsYi Chu; Min Luo; Wenyu Li; Xuehong Wang; Yuqian Zhou
Affiliations1. Department of Gastroenterology, The Second Xiangya Hospital of Central South University, China
63
days
Observational characterization of self-reported SR-17018 exposure and outcomes in individuals with prior opioid use histories
AuthorsMark P. Picard
Affiliations1. Independent Researcher, United States
70
days
The therapeutic potential of medicinal mushrooms in ophthalmology: from ethnomycology to evidence-based applications
AuthorsTibor Rák; Yu Jin; Meirong Chen; Adrienne Csutak
Affiliations1. Department of Ophthalmology, University of Pécs Medical School, Clinical Centre, Hungary; 2. Ophthalmology Department of Shandong Hospital of Traditional Chinese Medicine, China
71
days
Itaconate alleviates thioacetamide-induced acute liver injury by suppressing pyroptosis-associated mitochondrial dysfunction and activating the Nrf2/HO-1 pathway
AuthorsLianghong Lv; Wenchang Yang; Qian Yu; Zheng Ma; Song Wang; Yun Lu
Affiliations1. Department of Gastrointestinal Surgery, the Affiliated Hospital of Qingdao University, China; 2. Tumor Immunology and Cytotherapy of Medical Research Center, Shandong Provincial Key Laboratory of Clinical Research for Pancreatic Diseases, the Affiliated Hospital of Qingdao University, Qingdao University, China
133
days
Effect and mechanism of Emodin on mouse myeloid-derived suppressor cells
AuthorsYating Shu; Li Ma; Weiling Xiao; Xingyue Li; Xiaotian Qi; Meiyu Peng
Affiliations1. Key Laboratory of Immune Microenvironment and Inflammatory Disease Research in Universities of Shandong Province, School of Basic Medical Sciences, Shandong Second Medical University, China; 2. Digestive Disease Diagnosis and Treatment Center, Affiliated Hospital of Shandong Second Medical University, China; 3. Department of Nephrology, Affiliated Hospital of Shandong Second Medical University, China
207
days
Therapeutic advances in spinal muscular atrophy: a review of clinical, safety, and economic considerations
AuthorsAndrej Belančić; Elvira Meni Maria Gkrinia; Yun Wah Lam; Dinko Vitezić
Affiliations1. Department of Basic and Clinical Pharmacology and Toxicology, University of Rijeka, Faculty of Medicine, Croatia; 2. Independent Researcher, Greece; 3. Department of Health Sciences, School of Nursing and Health Sciences, Hong Kong Metropolitan University, Hong Kong SAR, China
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days